The National Cancer Research Institute (NCRI)

Step towards blood test for many cancer types

Scientists find more than 800 blood markers in cancer patients that could lead to a single blood test for early detection of cancer. Scientists find more than 800 blood markers in cancer patients that could lead to a single blood test for early detection of cancer.

2 November 2014

• Health & Medicine

‘Invisible tattoos’ could improve body confidence after breast cancer radiotherapy

Invisible tattoos could replace the permanent dark ink tattoos used to deliver breast cancer radiotherapy according to an NCRI Cancer Conference study. Invisible tattoos could replace the permanent dark ink tattoos used to deliver breast cancer radiotherapy according to an NCRI Cancer Conference study.

2 November 2014

Cancer cell fingerprints in the blood may speed up childhood cancer diagnosis

Newly-identified cancer cell fingerprints in the blood could one day help doctors diagnose a range of children’s cancers faster and more accurately. Newly-identified cancer cell fingerprints in the blood could one day help doctors diagnose a range of children’s cancers faster and more accurately.

1 November 2014

• Health & Medicine

Ethnic minorities less aware of cancer symptoms and more likely to identify barriers to seeking medical help

Ethnic minorities in England are less aware of cancer symptoms and more likely to say they wouldn’t see the doctor, according to new research. Ethnic minorities in England are less aware of cancer symptoms and more likely to say they wouldn’t see the doctor, according to new research.

1 November 2014

• Health & Medicine

Scientists trigger self-destruct switch in lung cancer cells

Scientists have found a drug combination that can trigger the self-destruct process in lung cancer cells. Scientists have found a drug combination that can trigger the self-destruct process in lung cancer cells.

31 October 2014

• Health & Medicine

Concern at lack of teenage patients in cancer trials

Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments

30 June 2014

• Health & Medicine

Funding for cancer research increases by over 60 per cent in 10 years

Funding for cancer research by National Cancer Research Institute Partners has increased by 62 per cent in the 10 years up to 2011. Funding for cancer research by National Cancer Research Institute Partners has increased by 62 per cent in the 10 years up to 2011.

13 November 2013

• Health & Medicine

Redirecting our immune cells to help fight children's cancer

Immune cells, known as Natural Killer T cells, could be redirected to help fight the childhood cancer, neuroblastoma, according to research. Immune cells, known as Natural Killer T cells, could be redirected to help fight the childhood cancer, neuroblastoma, according to research.

6 November 2013

• Health & Medicine

Round the clock A&E cancer doctors revolutionise treatment for patients

Having on-site cancer consultants in hospitals with Accident and Emergency departments improves diagnosis and treatment of patients. Having on-site cancer consultants in hospitals with Accident and Emergency departments improves diagnosis and treatment of patients.

6 November 2013

Cancer Research UK announces winners of 2013 research prizes

Cancer Research UK presented its prestigious Lifetime Achievement Award to the internationally acclaimed scientist Professor Sir Bruce Ponder. Cancer Research UK presented its prestigious Lifetime Achievement Award to the internationally acclaimed scientist Professor Sir Bruce Ponder.

5 November 2013

Prostate cancer test can spot the difference between aggressive and slow-growing tumours

A new test may overcome one of the biggest problems in prostate cancer treatment – telling slow-growing tumours from aggressive ones. A new test may overcome one of the biggest problems in prostate cancer treatment – telling slow-growing tumours from aggressive ones.

5 November 2013

• Health & Medicine

New drug extends life in women with advanced ovarian cancer

Women with ovarian cancer that returned after treatment had their life extended by almost three months after treatment with the drug cediranib. Women with ovarian cancer that returned after treatment had their life extended by almost three months after treatment with the drug cediranib.

5 November 2013